Discussion  by unknown
mended to confirm that there is no aneurysm formation at
the proximal anastomosis.
CONCLUSION
Despite the overall high technical and clinical success
rate of endovascular AAA repair, late failure remains a
persistent problem long after initial implantation. Unique
challenges are associated with removal of aortic endografts,
and preoperative planning requires careful consideration of
distinct differences between endograft designs. It is critical
to note that secondary conversion is a more difficult oper-
ation than primary open AAA repair. However, in most
patients explantation can be safely performed with low
morbidity.
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DISCUSSION
Dr Spence M. Taylor (Greenville, SC). Dr Brothers, Secre-
tary Hansen. You have just heard Dr Terramani and his associates
from Emory describe their approach to a new iatrogenic disease
that has developed over the past 10 years, namely, the treatment of
secondary failures of endovascular abdominal aortic aneurysms. In
this presentation they have described the findings and operative
techniques in managing nine patients who required secondary
conversion from endograft to open aneurysm. The paper focuses
nicely on the operative findings and on the methods the authors
used to deal with the unique circumstances that arise intraopera-
tively when treating this new “disease.” This is a small series, and
arguably could be considered a large case report. However, the
smaller size works to the advantage of the authors, allowing them
to detail specifics of management based on the findings of each
case. The authors successfully manage eight cases, with one patient
dying at postoperative day 21, for a perioperative mortality of 11%.
This manuscript, in my judgment, deserves publication because it
is very well-written, it is informative, and adds experience to the
growing collective series of endovascular repairs that need second-
ary conversion. Assuming the authors’ literature research, which
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you just heard, is correct, the cases presented today represent the
159th through the 167th cases reported to date.
I really have no problems with this paper, but for the sake of
opening the discussion, I was curious about certain parts that I
read. I have no query with the methods, the results, or the
discussion of this manuscript. However, I was troubled by the tone
of the introduction and by some of the conclusions drawn from the
findings of the study.
In the introduction it is not emphatically stated that endovas-
cular exclusion of abdominal aortic aneurysm should be considered
a treatment of choice for all aneurysms, but this notion is inferred.
Is this indeed the philosophy at Emory University? Is endovascular
exclusion the primary treatment of choice for all aneurysms that
present to your institution? It has been my bias that late failures of
treatment, and to a lesser extent early failures of treatment, that
lead to open conversions are the result of inappropriate patient
selection up front. If one simply reads the manufacturer’s instruc-
tions of each endovascular device and strictly adheres to the
anatomic criteria recommended for the use of the products, then
type 1 endoleaks, which may later require secondary conversion,
can generally be avoided. In this day of endo-exuberance, to steal
a phrase from the title of a paper to be presented later this morning,
there seems to be a tendency to “push the envelope,” whether it be
flare distal anastomoses or whatever, to apply the technique to
patients who may be marginal anatomic candidates.
While I realize that your series has a combined primary and
secondary conversion rate that is very acceptable, at 6.2%, I notice
it was higher than ours in Greenville. Our series of aortic en-
dografts is smaller than yours, at 270 cases, but we have had three
cases that have required conversion, two early and one late, for a
total conversion rate of 1.5%. Using Fisher’s exact test, our con-
version rate is statistically lower than yours, with a P value of .02.
Why is that? I don’t know. Philosophically, however, we try to
maintain strict adherence to the anatomic recommendations of the
manufacturer, and as well have advised open surgery for younger
patients. We have always felt that this has influenced our relatively
modest percentage of aneurysms that undergo endovascular treat-
ment, which in our hospital is about 37% to 40%. What percentage
of aneurysms at Emory are treated endovascularly? What are your
criteria for recommending endovascular therapy for patients who
present with aortic aneurysms? I wonder if my bias at the number
of late complications, namely, type 1 endoleaks and open conver-
sions, varies directly with the relative percentage of endovascular
stent grafts performed by a given group of surgeons.
Last, I was curious about a sentence in your conclusions.
Please forgive this pet peeve, but I am always troubled by any
concluding statement that has not been addressed in the methods
nor substantiated by the results of the experiment. You state in the
conclusion of your manuscript, and I quote, “improvements in
device design, increased operator experience, and advances in
diagnosis and management of endoleaks should continue to re-
duce the incidence of secondary conversion.” Excusing that none
of these topics were addressed in your study, thus disqualifying it as
a conclusion, do you really believe this? Do you not accept the
premise that there will always be technical limitations of these
devices, a notion that is accepted by many senior endovascular
surgeons from Europe and Australia, and that the real challenge
will be to understand these limitations so that we use the appro-
priate devices in the appropriate patients?
Again, I really enjoyed this paper. I recommend it to everyone,
and I appreciate the opportunity by the program committee to
comment.
Dr Terramani. Our philosophy at Emory is, aortic endografts
are not utilized for all patients with abdominal aortic aneurysms.
We are very selective in our patient selection, and it is a multifac-
torial equation that comes into play: aneurysm size greater than 5.5
cm, elderly patients, hostile abdomen from prior abdominal sur-
gery, prohibitive operative risk, life expectancy of at least 2 years or
greater, and suitable anatomical candidates. Our treatment of
choice for young patients with none of the above is open surgical
repair. Currently we treat about 50% of our abdominal aortic
aneurysm patients with endoluminal grafts.
What are our anatomical criteria for considering a patient an
endograft candidate? Aneurysm neck diameter less than 26 mm
and length greater than 15 mm, presence of minimal calcification
and/or thrombus in infrarenal aortic neck, less than 60-degree
neck angulation, adequate size of access vessels, and a 2 cm distal
landing zone.
In regard to your comments about our conclusion, this was
basically an observational study, and we believe our conclusion
stems from looking at our experience. In our endograft secondary
conversions, many of them were with devices that have undergone
substantial modifications, and one device has been taken off the
market completely. The highest percentage of endograft-specific
explanation was the EVT tube graft (10.7%), and this graft is no
longer available. We feel that improvements in the device design
are going to reduce the secondary conversion rate as well as reduce
the primary conversion rates at the same time. The increased
operative experience, along with the increased knowledge of the
associated pitfalls, device limitations, and better patient selection,
should reduce the occurrence of device conversions.
Last, the advancements in the treatment of endoleaks are an
evolving process. Type II endoleaks were treated with microcath-
eterization or translumbar technique to coil embolize the feeding
vessels. Recently there was a report showing a direct transabdom-
inal approach and entering the aneurysm sac to ligate the feeding
vessels from within the sac. In addition, there have been several
reports of laparoscopic management of endoleaks. Therefore the
management of endoleaks is an evolving process, and as we get
more experience in this field, fewer endografts will have to be
explanted for endoleak-related problems.
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